Elevance Health Draws Fresh Capital Inflows, According to Recent Filing

DAVENPORT & Co LLC added 353,748 shares of Elevance Health (NYSE:ELV), an estimated $110.02 million trade based on the average price for the quarter, per an October 15, 2025, SEC filing.According to a filing with the Securities and Exchange Commission dated October 15, 2025, DAVENPORT & Co LLC purchased 353,748 additional shares of Elevance Health. The estimated transaction value was approximately $110.02 million, based on the average closing price for the period from July 1 through September 30, 2025. The fund reported holding 630,203 shares at quarter-end.This buy brings the stake to 1.08% of DAVENPORT & Co LLC's $18.76 billion reportable U.S. equity assets under management.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool